Article metrics

Efficacy and safety of peficitinib (ASP015K) in patients with rheumatoid arthritis and an inadequate response to conventional DMARDs: a randomised, double-blind, placebo-controlled phase III trial (RAJ3)

 

Online download statistics by month:

Online download statistics by month: July 2019 to April 2021

AbstractFullPdf
Jul 2019593596222
Aug 2019850870341
Sep 2019760755215
Oct 2019465449193
Nov 201922422096
Dec 2019198191111
Jan 202028527393
Feb 202020019585
Mar 202018417779
Apr 2020155149123
May 2020160160125
Jun 202012912572
Jul 202013212393
Aug 202012111669
Sep 202022522192
Oct 202012712394
Nov 202011811161
Dec 202012210756
Jan 20211049456
Feb 202110810068
Mar 2021958956
Apr 20211089752
Total546353412452